De-Risking Orphan GPCR Discovery to Transforming Novel Biology into Clinical-Stage Therapeutics
9:00 am - Wednesday 3rd March 2027
- Establishing confidence in novel GPCR targets through rigorous biological and translational validation
- Overcoming the scientific challenges associated with discovering therapies against receptors with limited historical characterization
- Accelerating progression from target hypothesis to clinical development through an integrated discovery strategy
